PR NEWSWIRE

Previous Stories

Annature transforms eSigning & ID automation with Xero Practice Manager

Sep 06 2022 - PR NewsWire

A customised dashboard delivers the industry’s first seamless automation for eSigned and ID Verification documentation from either platform BRISBANE, Australia,…


Prospection partners with leading Japanese healthcare data provider Medical Data Vision to improve treatment access for patients

Sep 06 2022 - PR NewsWire

SYDNEY, Sept. 6, 2022 /PRNewswire/ — Health analytics pioneer, Prospection has announced a unique global data access agreement with leading…


Nintex Appoints Jon “Jet” Theuerkauf as its new Chief Customer Officer

Sep 06 2022 - PR NewsWire

Company appoints industry exec to lead customer advocacy programs and professional services MELBOURNE, Australia, Sept. 6, 2022 /PRNewswire/ — Nintex,…


OrionVM and ELO Digital Office Australia Launch New Cloud Solution for Enterprise Content Management

Sep 05 2022 - PR NewsWire

New IaaS partnership with OrionVM delivers secure, scalable and fast performing cloud environments for ELO’s ECM customers SYDNEY, Sept. 5,…


Homely releases FY22 results, announces 58% annualised revenue growth, strengthening industry support.

Sep 05 2022 - PR NewsWire

MELBOURNE, Australia, Sept. 5, 2022 /PRNewswire/ –  Highlights from Homely’s full year results Revenue increased 58% YoY 49% revenue growth…


Sungrow To Supply Australia’s Largest DC-coupled Solar plus Storage Project with its Liquid-Cooled ESS PowerTitan

Sep 05 2022 - PR NewsWire

SYDNEY, Sept. 5, 2022 /PRNewswire/ — Sungrow, the global leading inverter and energy storage solution provider for renewables, announced that…


TrafficGuard Extends Ad Protection to Facebook Ads with “TrafficGuard Social”

Sep 05 2022 - PR NewsWire

PERTH, Australia, Sept. 5, 2022 /PRNewswire/ – Leading omnichannel digital ad verification and fraud prevention platform, TrafficGuard, today launched TrafficGuard Social,…


Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

Sep 05 2022 - PR NewsWire

– CornerStone-001(NCT05163223), the multiregional clinical trial for breast cancer treatment, received U.S. FDA approval for Phase 2 trial following the approvals in Australia and…


LEADERS IN NUTRITIONAL MEDICINE ON CUSP OF BREAKTHROUGH GUIDELINES TO TACKLE LONG-COVID SYMPTOMS

Sep 05 2022 - PR NewsWire

Guidelines for health practitioner diagnosis of Long-COVID are in review Understanding of mitochondrial health integral to post-pandemic recovery, say experts…


Sims Limited Appoints Philip Bainbridge to Board of Directors

Sep 01 2022 - PR NewsWire

– Independent Non-Executive Director fills casual vacancy on the Board – SYDNEY, Sept. 1, 2022 /PRNewswire/ — Sims Limited, a…


Analyse The Market From A Different Angle